The model uses clinical and genomic features to predict whether patients will respond to first-line CDK4/6 and endocrine therapy.

University of Californi, San Francisco Foundation to support advancing Multimodal Biosensing (MMBS) at Neuroscape to leverage AI and data science to gain a deeper understanding of an individual's ...